Addiction Medicine: Closing the Gap between Science and Practice

(lu) #1

Addolorato, G., Leggio, L., Ferrulli, A., Cardone, S., Vonghia, L., Mirijello, A., et al. (2007).
Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent
patients with liver cirrhosis: Randomized, double-blind controlled study. Lancet, 370(9603), 1915-
1922.


Adelmann, P. K. (2003). Mental and substance use disorders among Medicaid recipients: Prevalence
estimates from two national surveys. Administration & Policy in Mental Health, 31(2), 111-129.


Advocates for Human Potential. (2009). An environmental scan of the impact of parity: Practical
implications of the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act
of 2008 (AHP Behavioral Parity series White Paper #1). Sudbury, MA: Author.


Advocates for Human Potential. (2010). Special report: MHPAEA regulations: Operational analysis of
the mental health parity and addiction equity act interim final rule. Sudbury, MA: Author.


Agency for Healthcare Research and Quality. (2003). Program note 6: Compendium of AHRQ research
related to mental health (AHRQ Pub. No. 03-0001). [Online]. Retrieved April 18, 2012 from
http://www.ahrq.gov.


Agency for Healthcare Research and Quality. (2010). Guideline summary NGC-4931: Detoxification and
substance abuse treatment: An overview of the psychosocial and biomedical issues during
detoxification. [Online]. Retrieved December 13, 2011 from http://www.ngc.gov.


Agency for Healthcare Research and Quality. (2012a). About national quality measures clearinghouse
(NQMC). [Online]. Retrieved April 18, 2012 from http://www.qualitymeasures.ahrq.gov.


Agency for Healthcare Research and Quality. (2012b). Guideline index. [Online]. Retrieved April 18,
2012 from http://www.guideline.gov.


Agency for Healthcare Research and Quality. (2012c). Guidelines by topic. [Online]. Retrieved June 5,
2012 from http://guideline.gov.


Agency for Healthcare Research and Quality. (2012d). Medical expenditure panel survey. Table 3: Total
expenses and percent distribution for selected conditions by type of service: United States, 2009.
[Online]. Retrieved April 3, 2012 from http://meps.ahrq.gov.


Agency Medical Directors Group. (2012). Interagency guideline on opioid dosing for chronic non-cancer
pain: An educational aid to improve care and safety with opioid therapy: 2010 update. [Online].
Retrieved May 31, 2012 from http://www.agencymeddirectors.wa.gov.


Agrawal, A., & Lynskey, M. T. (2006). The genetic epidemiology of cannabis use, abuse and
dependence. Addiction, 101(6), 801-812.


Agrawal, A., & Lynskey, M. T. (2008). Are there genetic influences on addiction: Evidence from family,
adoption and twin studies. Addiction, 103(7), 1069-1081.


Agrawal, A., Sartor, C. E., Lynskey, M. T., Grant, J. D., Pergadia, M. L., Grucza, R., et al. (2009).
Evidence for an interaction between age at first drink and genetic influences on DSM-IV alcohol
dependence symptoms. Alcoholism: Clinical & Experimental Research, 33(12), 2047-2056.


Akpanudo, S. M., Price, J. H., Jordan, T., Khuder, S., & Price, J. A. (2009). Clinical psychologists and
smoking cessation: Treatment practices and perceptions. Journal of Community Health, 34(6), 461-
471.


Ala. Code 580 § 2-9.03 (2012).


Alaska Admin. Code 7, § 12.110 (January 2012).

Free download pdf